Eton Pharmaceuticals, and MiMedx Group. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Bioventus with a $14.00 average price target. BVS market cap is ...

Bank of New York Mellon Corp increased its holdings in Bioventus Inc. (NYSE:BVS – Free Report) by 37.4% in the fourth quarter ...

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...

Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Ascendis Pharma (ASND – Research Report) today and set a price target of $180.00. The company’s shares closed last Friday at ...

ANTIPOLO — When Petro Gazz was left gobsmacked in a stunning Game One sweep loss to ZUS Coffee, Brooke Van Sickle knew just who to call for help. The former PVL MVP had the luxury of her parents ...

Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "Pharma 4.0 - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Pharma 4 was valued ...

leading-edge R&D and radiopharmaceutical manufacturing infrastructure (PRNewsfoto/Actinium Pharmaceuticals, Inc.) Sandesh Seth, Actinium's Chairman and CEO, said, "We are honored to have this ...

March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...

WASHINGTON, March 24 (Reuters) - U.S. President Donald Trump said on Monday he will in the very near future announce tariffs on automobiles, aluminum and pharmaceuticals. Speaking to reporters at ...

Opinions expressed are those of the author. 2025 is going to be a big year for AI adoption in pharma. By now, most life science companies have at least experimented with one generative AI (GenAI ...

Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Most of the major U.S. pharmaceutical companies (AbbVie, Amgen, Bristol Myers ...

Hampton was appointed by the Justice Department in 2019 to represent the financial interests of victims in the Purdue Pharma bankruptcy case. For two years, he served on a committee of creditors.